Incidence of brucella abortus and Brucella Melitensis in Peshawar and identification of active and passive infection

Life Science Journal

Volumn 11, Issue 10 SPEC. ISSUE, 2014, Pages 1-5

  Ahmad, Bashir ^a   Jamil, Saira ^a   Bashir, Shumaila ^a   Bilal, M ^a   Hassan, Said ^a   Khan, Javid ^b  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b Departments of Pharmacy University of Peshawar ^*  (United Kingdom)

Author keywords

Acute; Brucella Abortus; Brucella Melitensis; Brucellosis; Chronic; ELISA; IgG; IgM; Incidence rate; Slide agglutination test

Indexed keywords

EID: 84902457773     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wafa Al-Nassir. Brucellosis Clinical Presentation. MedScape, 2013.
2. Chamberlain NR. Brucellosis in Medical Microbiology CBS Publ, 2003; 3:271-275.
3. Yagupsky P, EJ Baron. Laboratory exposures to Brucellae and implications for bioterrorism. J Emerg Infect Dis, 2005; 11:1180-1185.
4. Schelling E, Diguimbaye C, Daoud S, Nicolet J, Boerlin P, Tanner M and Zinsstag J. Brucellosis and Q-fever sero-prevalence of nomadic pastoralists and their livestock in Chad. Prev Vet Med, 2003; 61:279-293.
5. Nasir WA. Brucellosis. Website: [http://emedicine.medscape.com/article/213430-overview] 2011.
6. Memish Z. Brucellosis Control in Saudi Arabia: Prospects and Challenges. J Chemother, 2001; 13:11-17.
7. Abdul QK, Humaira Z, Kiran TB. Comparative studies of the human brucellosis (Malta Fever) in two provinces (Khyber Pakhtunkhwa and Punjab) in patients suffering from febrile illness and cases of PUO (Pyrexia of unknown origin). IMJ, 2012; 4:143-7.
8. Spink WW, Anderson D. Correlation of a rapid slide-agglutination test (Castaneda) with a tube-agglutination test in screening suspected cases of human brucellosis. J Lab Clin Med, 1952; 40(4):593-600.
9. Magee JT. An enzyme-labelled immunosorbant assay for Brucella abortus antibodies. J Med Microbial, 1980; 13:167-72.
10. Gul ST, Khan A. Epidemiology and epizootology of brucellosis: A review. Pak Vet J, 2007; 27:145-151.
11. Bokaie S, Heydari S, Abbaszadeh S, Mousakhani H. Ecological study of brucellosis in humans and animals in Khoy, a mountainous District of the IR. of Iran. IJM, 2009; 1:14-17.
12. Haldun S, Zeynep S, Ahmet A, Naim N, Levent O. Seroprevalence of Brucella in an Elderly Population in Mid-Anatolia, Turkey. Journal of Health Population and Nutrition, 2003; 21(2):158-161.
13. Araj GF. Update on laboratory diagnosis of human Brucellosis. J Antimicrobial Agents, 2010; 36(1):12-7.
14. Brodly JA, Huntley B, Theresa A, Maynard OJ. Studies of human Brucellosis in Alaska. J Infect Dis, 1966; 116(3):263-9.
15. Lucero NE, Foglia L, Ayala SM, Gall D, Nielson K. Competitive enzyme immunoassay for diagnosis of human Brucellosis. J Clin Microbiol, 1999; 37(10):3245-8.
16. Lulu AR., Araj GF, Khateeb M. Human Brucellosis in Kuwait: A Prospective Study of 400 Cases. PMC, 1987; 12(11): 1334-1335.
17. Araj GF, Lulu AR, Mustafa MY, Khateeb MI. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. Journal of Hygiene, 1986; 97:457-469.
18. Tamar A, Danielle V, Giulen C, Otar Z and Matthew J. The changing pattern of human brucellosis: clinical manifestations, epidemiology, and treatment outcomes over three decades in Georgia. MC Infectious Diseases, 2010; 10:346.
19. Mustafa E, Halil Y, Ayten K. Complications of brucella infection among adults: an 18-year retrospective evaluation. Turk J Med Sci, 2006; 36 (6): 377-381.
20. Memish ZA, Almuneef M, Mah MW, Qassem LA, Osoba AO. Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia. Pub Med, 2002; 44(2):129-32.